Guideline |
| Alberts WM, Bepler G, Hazelton T, Ruckdeschel JC, Williams JH Jr, American College of Chest Physicians., Lung cancer. Practice organization. Chest, 2003 Jan;123(1 Suppl):332S-337S | 2003 |
| Robinson LA, Wagner H Jr, Ruckdeschel JC, American College of Chest Physicians., Treatment of stage IIIA non-small cell lung cancer. Chest, 2003 Jan;123(1 Suppl):202S-220S | 2003 |
Journal Article |
| Schneider BJ, Kalemkerian GP, Gadgeel SM, Valdivieso M, Hackstock DM, Chen W, Heilbrun LK, Ruckdeschel JC, Wozniak AJ, Phase II Trial of Dose-dense Pemetrexed, Gemcitabine, and Bevacizumab in Patients With Advanced, Non-Small-cell Lung Cancer. Clinical lung cancer, 2017 May;18(3):299-302 | 2017 |
| Miller AT, Kruger P, Conner K, Robertson T, Rowley B, Sause W, Ruckdeschel JC, Blagev DP, Initial Outcomes of a Lung Cancer Screening Program in an Integrated Community Health System. Journal of the American College of Radiology : JACR, 2016 Jun;13(6):733-7 | 2016 |
| Hahn EE, Tang T, Lee JS, Munoz-Plaza CE, Shen E, Rowley B, Maeda JL, Mosen DM, Ruckdeschel JC, Gould MK, Use of posttreatment imaging and biomarkers in survivors of early-stage breast cancer: Inappropriate surveillance or necessary care? Cancer, 2016 Mar 15;122(6):908-16 | 2016 |
| Hahn EE, Tang T, Lee JS, Munoz-Plaza C, Adesina JO, Shen E, Rowley B, Maeda JL, Mosen DM, Ruckdeschel JC, Gould MK, Use of imaging for staging of early-stage breast cancer in two integrated health care systems: adherence with a choosing wisely recommendation. Journal of oncology practice, 2015 May;11(3):e320-8 | 2015 |
| Krug LM, Wozniak AJ, Kindler HL, Feld R, Koczywas M, Morero JL, Rodriguez CP, Ross HJ, Bauman JE, Orlov SV, Ruckdeschel JC, Mita AC, Fein L, He X, Hall R, Kawabe T, Sharma S, Randomized phase II trial of pemetrexed/cisplatin with or without CBP501 in patients with advanced malignant pleural mesothelioma. Lung cancer (Amsterdam, Netherlands), 2014 Sep;85(3):429-34 | 2014 |
| Karp DD, Lee SJ, Keller SM, Wright GS, Aisner S, Belinsky SA, Johnson DH, Johnston MR, Goodman G, Clamon G, Okawara G, Marks R, Frechette E, McCaskill-Stevens W, Lippman SM, Ruckdeschel J, Khuri FR, Randomized, double-blind, placebo-controlled, phase III chemoprevention trial of selenium supplementation in patients with resected stage I non-small-cell lung cancer: ECOG 5597. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013 Nov 20;31(33):4179-87 | 2013 |
| Northouse LL, Mood DW, Schafenacker A, Kalemkerian G, Zalupski M, LoRusso P, Hayes DF, Hussain M, Ruckdeschel J, Fendrick AM, Trask PC, Ronis DL, Kershaw T, Randomized clinical trial of a brief and extensive dyadic intervention for advanced cancer patients and their family caregivers. Psycho-oncology, 2013 Mar;22(3):555-63 | 2013 |
| Orom H, Cline RJ, Hernandez T, Berry-Bobovski L, Schwartz AG, Ruckdeschel JC, A Typology of Communication Dynamics in Families Living a Slow-Motion Technological Disaster. Journal of family issues, 2012 Oct;33(10):1299-1323 | 2012 |
| Gadgeel SM, Ruckdeschel JC, Patel BB, Wozniak A, Konski A, Valdivieso M, Hackstock D, Chen W, Belzer K, Burger AM, Marquette L, Turrisi A, Phase II study of pemetrexed and cisplatin, with chest radiotherapy followed by docetaxel in patients with stage III non-small cell lung cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2011 May;6(5):927-33 | 2011 |
| Soubani AO, Ruckdeschel JC, The outcome of medical intensive care for lung cancer patients: the case for optimism. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2011 Mar;6(3):633-8 | 2011 |
| Turner JF, Khoury JD, Ruckdeschel JC, Granulomatous solitary pulmonary nodule. Journal of bronchology & interventional pulmonology, 2011 Jan;18(1):111-2 | 2011 |
| Schneider BJ, Kalemkerian GP, Ramnath N, Kraut MJ, Wozniak AJ, Worden FP, Ruckdeschel JC, Zhang X, Chen W, Gadgeel SM, Phase II trial of imatinib maintenance therapy after irinotecan and cisplatin in patients with c-Kit-positive, extensive-stage small-cell lung cancer. Clinical lung cancer, 2010 Jul 1;11(4):223-7 | 2010 |
| Cline RJ, Orom H, Berry-Bobovski L, Hernandez T, Black CB, Schwartz AG, Ruckdeschel JC, Community-level social support responses in a slow-motion technological disaster: the case of Libby, Montana. American journal of community psychology, 2010 Sep;46(1-2):1-18 | 2010 |
| Wang Y, Rishi AK, Puliyappadamba VT, Sharma S, Yang H, Tarca A, Dou QP, Lonardo F, Ruckdeschel JC, Pass HI, Wali A, Targeted proteasome inhibition by Velcade induces apoptosis in human mesothelioma and breast cancer cell lines. Cancer chemotherapy and pharmacology, 2010 Aug;66(3):455-66 | 2010 |
| Pena T, LoRusso PM, Ruckdeschel JC, Goncalves P, Soubani AO, Pulmonary metastasis of basal cell carcinoma: a rare manifestation of a common disease with variable clinical course. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2009 Aug;4(8):1026-7 | 2009 |
| Schwartz AG, Cote ML, Wenzlaff AS, Van Dyke A, Chen W, Ruckdeschel JC, Gadgeel S, Soubani AO, Chronic obstructive lung diseases and risk of non-small cell lung cancer in women. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2009 Mar;4(3):291-9 | 2009 |
| Gleason ME, Harper FW, Eggly S, Ruckdeschel JC, Albrecht TL, The influence of patient expectations regarding cure on treatment decisions. Patient education and counseling, 2009 May;75(2):263-9 | 2009 |
| Gadgeel SM, Wozniak A, Ruckdeschel JC, Heilbrun LK, Venkatramanamoorthy R, Chaplen RA, Kraut MJ, Kalemkerian GP, Phase II study of docetaxel and celecoxib, a cyclooxygenase-2 inhibitor, in elderly or poor performance status (PS2) patients with advanced non-small cell lung cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2008 Nov;3(11):1293-300 | 2008 |
| Whitehouse AC, Black CB, Heppe MS, Ruckdeschel J, Levin SM, Environmental exposure to Libby Asbestos and mesotheliomas. American journal of industrial medicine, 2008 Nov;51(11):877-80 | 2008 |
| Penner LA, Cline RJ, Albrecht TL, Harper FW, Peterson AM, Taub JM, Ruckdeschel JC, Parents' Empathic Responses and Pain and Distress in Pediatric Patients. Basic and applied social psychology, 2008 Apr 1;30(2):102-113 | 2008 |
| Eggly S, Albrecht TL, Harper FW, Foster T, Franks MM, Ruckdeschel JC, Oncologists' recommendations of clinical trial participation to patients. Patient education and counseling, 2008 Jan;70(1):143-8 | 2008 |
| Robinson LA, Ruckdeschel JC, Wagner H Jr, Stevens CW, American College of Chest Physicians., Treatment of non-small cell lung cancer-stage IIIA: ACCP evidence-based clinical practice guidelines (2nd edition). Chest, 2007 Sep;132(3 Suppl):243S-265S | 2007 |
| Welch Cline RJ, Penner LA, Harper FW, Foster TS, Ruckdeschel JC, Albrecht TL, The roles of patients' internet use for cancer information and socioeconomic status in oncologist-patient communication. Journal of oncology practice, 2007 May;3(3):167-71 | 2007 |
| Gadgeel SM, Ruckdeschel JC, Heath EI, Heilbrun LK, Venkatramanamoorthy R, Wozniak A, Phase II study of gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI), and celecoxib, a cyclooxygenase-2 (COX-2) inhibitor, in patients with platinum refractory non-small cell lung cancer (NSCLC). Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2007 Apr;2(4):299-305 | 2007 |
| Eggly S, Penner LA, Greene M, Harper FW, Ruckdeschel JC, Albrecht TL, Information seeking during "bad news" oncology interactions: Question asking by patients and their companions. Social science & medicine (1982), 2006 Dec;63(11):2974-85 | 2006 |
| Albrecht TL, Kuerer H, Ruckdeschel JC, Mendez J, Harper F, American College of Surgeons Oncology Group., Transdisciplinary studies of surgical oncology trial accrual: A National Institutes of Health/National Cancer Institute Roadmap-affiliated project update. Cancer, 2006 Jul 1;107(1):171-4 | 2006 |
| Eggly S, Penner L, Albrecht TL, Cline RJ, Foster T, Naughton M, Peterson A, Ruckdeschel JC, Discussing bad news in the outpatient oncology clinic: rethinking current communication guidelines. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006 Feb 1;24(4):716-9 | 2006 |
| Schwartz AG, Ruckdeschel JC, Familial lung cancer: genetic susceptibility and relationship to chronic obstructive pulmonary disease. American journal of respiratory and critical care medicine, 2006 Jan 1;173(1):16-22 | 2006 |
| Albrecht TL, Ruckdeschel JC, Ray FL 3rd, Pethe BJ, Riddle DL, Strohm J, Penner LA, Coovert MD, Quinn G, Blanchard CG, A portable, unobtrusive device for videorecording clinical interactions. Behavior research methods, 2005 Feb;37(1):165-9 | 2005 |
| Coté ML, Kardia SL, Wenzlaff AS, Ruckdeschel JC, Schwartz AG, Risk of lung cancer among white and black relatives of individuals with early-onset lung cancer. JAMA, 2005 Jun 22;293(24):3036-42 | 2005 |
| Albrecht TL, Franks MM, Ruckdeschel JC, Communication and informed consent. Current opinion in oncology, 2005 Jul;17(4):336-9 | 2005 |
| Ruckdeschel JC, Early detection and treatment of spinal cord compression. Oncology (Williston Park, N.Y.), 2005 Jan;19(1):81-6; discussion 86, 89-92 | 2005 |
| Larson GP, Ding Y, Cheng LS, Lundberg C, Gagalang V, Rivas G, Geller L, Weitzel J, MacDonald D, Archambeau J, Slater J, Neuberg D, Daly MB, Angel I, Benson AB 3rd, Smith K, Kirkwood JM, O'Dwyer PJ, Raskay B, Sutphen R, Drew R, Stewart JA, Werndli J, Johnson D, Ruckdeschel JC, Elston RC, Krontiris TG, Genetic linkage of prostate cancer risk to the chromosome 3 region bearing FHIT. Cancer research, 2005 Feb 1;65(3):805-14 | 2005 |
| Ninane V, Le Pechoux C, Curran W, Furuse K, Liptay M, Meert AP, Paesmans M, Rami-Porta R, Roelandts M, Ruckdeschel JC, Sculier JP, Senan S, Smit EF, Critical factors for patient management. Lung cancer (Amsterdam, Netherlands), 2003 Dec;42 Suppl 1:S7-8 | 2003 |
| Albrecht TL, Ruckdeschel JC, Riddle DL, Blanchard CG, Penner LA, Coovert MD, Quinn G, Communication and consumer decision making about cancer clinical trials. Patient education and counseling, 2003 May;50(1):39-42 | 2003 |
| Chirikos TN, Ruckdeschel JC, Krischer JP, Impact of clinical trials on the cost of cancer care. Medical care, 2001 Apr;39(4):373-83 | 2001 |
| Simon G, Ginsberg RJ, Ruckdeschel JC, Small-cell lung cancer. Chest surgery clinics of North America, 2001 Feb;11(1):165-88, ix | 2001 |
| Bennett CL, Stinson TJ, Vogel V, Robertson L, Leedy D, O'Brien P, Hobbs J, Sutton T, Ruckdeschel JC, Chirikos TN, Weiner RS, Ramsey MM, Wicha MS, Evaluating the financial impact of clinical trials in oncology: results from a pilot study from the Association of American Cancer Institutes/Northwestern University clinical trials costs and charges project. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000 Aug;18(15):2805-10 | 2000 |
| Ruckdeschel JC, Update in oncology. Annals of internal medicine, 1999 Nov 16;131(10):760-7 | 1999 |
| Albrecht TL, Blanchard C, Ruckdeschel JC, Coovert M, Strongbow R, Strategic physician communication and oncology clinical trials. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1999 Oct;17(10):3324-32 | 1999 |
| Ruckdeschel JC, Gridelli C, Perrone F, Monfardini S, Giaccone G, Are platinum compounds mandatory in the treatment of metastatic non-small cell lung cancer? European journal of cancer (Oxford, England : 1990), 1998 Dec;34(13):1993-9 | 1998 |
| Ruckdeschel JC, Future directions in non-small-cell lung cancer: a continuing perspective. Oncology (Williston Park, N.Y.), 1998 Jan;12(1 Suppl 2):90-6 | 1998 |
| Tockman MS, Mulshine JL, Piantadosi S, Erozan YS, Gupta PK, Ruckdeschel JC, Taylor PR, Zhukov T, Zhou WH, Qiao YL, Yao SX, Prospective detection of preclinical lung cancer: results from two studies of heterogeneous nuclear ribonucleoprotein A2/B1 overexpression. Clinical cancer research : an official journal of the American Association for Cancer Research, 1997 Dec;3(12 Pt 1):2237-46 | 1997 |
| Pisters KM, Kris MG, Bunn PA Jr, Johnson DH, Ruckdeschel JC, Crowley JJ, Ginsberg RJ, Induction paclitaxel/carboplatin in early stage non-small cell lung cancer. Bimodality Lung Oncology Team. Seminars in oncology, 1997 Aug;24(4 Suppl 12):S12-41-S12-44 | 1997 |
| Ruckdeschel JC, Combined modality therapy of non-small cell lung cancer. Seminars in oncology, 1997 Aug;24(4):429-39 | 1997 |
| Antonia S, Ruckdeschel JC, Improving Our Management of Non-Small Cell Lung Cancer and Mesothelioma. Cancer control : journal of the Moffitt Cancer Center, 1997 Jul;4(4):293 | 1997 |
| Blanchard CG, Albrecht TL, Ruckdeschel JC, The crisis of cancer: psychological impact on family caregivers. Oncology (Williston Park, N.Y.), 1997 Feb;11(2):189-94; discussion 196, 201-2 | 1997 |
| Ruckdeschel JC, Preoperative paclitaxel plus carboplatin for patients with intermediate-risk non-small cell lung cancer. Seminars in oncology, 1996 Dec;23(6 Suppl 16):62-7 | 1996 |
| Spiers AS, Esseltine DL, Ruckdeschel JC, Davies JN, Horton J, Metastatic Adenoid Cystic Carcinoma of Salivary Glands: Case Reports and Review of the Literature. Cancer control : journal of the Moffitt Cancer Center, 1996 Jul;3(4):336-342 | 1996 |
| Wagner H Jr, Ruckdeschel JC, Screening, Early Detection, and Early Intervention Strategies for Lung Cancer. Cancer control : journal of the Moffitt Cancer Center, 1995 Nov;2(6):493-502 | 1995 |
| Stock HS, Rosellini RA, Abrahamsen GC, McCaffrey RJ, Ruckdeschel JC, Methotrexate does not interfere with an appetitive Pavlovian conditioning task in Sprague-Dawley rats. Physiology & behavior, 1995 Nov;58(5):969-73 | 1995 |
| Ruckdeschel JC, Rapid, Cost-Effective Diagnosis of Spinal Cord Compression Due to Cancer. Cancer control : journal of the Moffitt Cancer Center, 1995 Jul;2(4):320-323 | 1995 |
| Ruckdeschel JC, Future directions in non-small cell lung cancer. A personal view. Lung cancer (Amsterdam, Netherlands), 1995 Jun;12 Suppl 2:S147-52 | 1995 |
| Ruckdeschel JC, Management of malignant pleural effusions. Seminars in oncology, 1995 Apr;22(2 Suppl 3):58-63 | 1995 |
| Tockman MS, Erozan YS, Gupta P, Piantadosi S, Mulshine JL, Ruckdeschel JC, The early detection of second primary lung cancers by sputum immunostaining. LCEWDG Investigators. Lung Cancer Early Detection Group. Chest, 1994 Dec;106(6 Suppl):385S-390S | 1994 |
| Linnoila RI, Piantadosi S, Ruckdeschel JC, Impact of neuroendocrine differentiation in non-small cell lung cancer. The LCSG experience. Chest, 1994 Dec;106(6 Suppl):367S-371S | 1994 |
| Ruckdeschel JC, Piantadosi S, Quality of life in lung cancer surgical adjuvant trials. Chest, 1994 Dec;106(6 Suppl):324S-328S | 1994 |
| Ruckdeschel JC, Lung Cancer: Time for an End to Nihilism. Cancer control : journal of the Moffitt Cancer Center, 1994 Oct;1(5):430-431 | 1994 |
| Ruckdeschel JC, The future role of carboplatin. Seminars in oncology, 1994 Oct;21(5 Suppl 12):114-8 | 1994 |
| Ruckdeschel JC, Blanchard CG, Albrecht T, Psychosocial oncology research. Where we have been, where we are going, and why we will not get there. Cancer, 1994 Aug 15;74(4 Suppl):1458-63 | 1994 |
| Holmes EC, Ruckdeschel JC, Preoperative chemotherapy for locally advanced non-small cell lung cancer. Seminars in oncology, 1994 Jun;21(3 Suppl 6):97-100 | 1994 |
| Ruckdeschel JC, Special Report: Lung Cancer Study Group - Final Analysis. Cancer control : journal of the Moffitt Cancer Center, 1994 May;1(3):283-285 | 1994 |
| Shaw GL, Falk RT, Deslauriers J, Nesbitt JC, McKneally MF, Frame JN, Feld R, Issaq HJ, Ruckdeschel JC, Hoover RN, Lung tumor resection does not affect debrisoquine metabolism. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 1994 Mar;3(2):141-4 | 1994 |
| Ruckdeschel JC, Therapeutic options for the treatment of small cell and non-small cell lung cancer. Current opinion in oncology, 1993 Mar;5(2):323-34 | 1993 |
| Ruckdeschel JC. Special problems in the older cancer patient: spinal cord compression and pleural effusions. Oncology. 1992;6(2):119-23. | 1992 |
| Remick SC, Ruckdeschel JC. Extrapulmonary and pulmonary small-cell carcinoma: tumor biology, therapy and outcome. Med Pediatr Oncol. 1992;20:89-99. | 1992 |
| Ruckdeschel JC. Chemotherapy of metastatic non-small cell carcinoma of the lung. Hematol Oncol. 1992;10:25-30 | 1992 |
| Ruckdeschel JC, Modi SP, el-Hamouly W, Portuese E, Archer S, N-methylcarbamate derivatives of ellipticine and olivacine with cytotoxic activity against four human lung cancer cell lines. Journal of medicinal chemistry, 1992 Dec 25;35(26):4854-7 | 1992 |
| Ruckdeschel JC, The role of standard-dose etoposide in the management of non-small cell lung cancer. Seminars in oncology, 1992 Dec;19(6 Suppl 13):39-44 | 1992 |
| Ruckdeschel JC, Special problems in the older cancer patient: spinal cord compression and pleural effusions. Oncology (Williston Park, N.Y.), 1992 Feb;6(2 Suppl):119-23 | 1992 |
| Kobassa SCO, Spinetta JJ, Cohen J, Crano WD, Hatchett S, Kaplan BH, Lansky SB, Prout MN, Ruckdeschel JC, Siegel K, Wellisch DK. Social environment and social support. Cancer. 1991;67 (suppl 1):788-93. | 1991 |
| Johnson DH, Ruckdeschel JC, Keller JH, Lyman GH, Kallas GJ, MacDonald J, DeConti RC, Lee J. A randomized trial to compare intravenous and orally administered etoposide in combination with cisplatin for the treatment of small cell lung cancer. Cancer. 1991;67(suppl):245. | 1991 |
| Remick SC, Harper GR, Abdullah MA, McSharry JJ, Ross JS, Ruckdeschel JC. Metastatic breast cancer in a young patient seropositive for human immunodeficiency virus. J Natl Cancer Inst. 1991;83:447. | 1991 |
| Labrecque MS, Blanchard CG, Ruckdeschel JC, Blanchard EB. The impact of family presence on the physician cancer patient interaction. Soc Sci Med. 1991;33:1253-61. | 1991 |
| Ruckdeschel JC, Piantadosi S, and the LCSG. Quality-of-life assessment in lung surgery for bronchogenic carcinoma. Theor Surg. 1991;6:201-5. | 1991 |
| Ruckdeschel JC, Moores D, Lee JY, Einhorn LH, Mandelbaum I, Koeller J, Weiss GR, Losada M, Keller J Intrapleural therapy for malignant pleural effusions: a randomized comparison of bleomycin and tetracycline. Chest. 1991;100:1528-35. | 1991 |
| Henry DH, Beall GN, Benson CA, Carey J, Cone L, Eron LJ, Fiala M, Fischl M, Gabin S, Galpin J, Gottlieb M, Groopman JE, Hooton T, Jemsek J, Levine R, Miles S, Rinehart JJ, Rios A, Robbins W, Ruckdeschel JC, Smith J, Spruance S, Starrett B, Toney J, Zalusky R, Abels R, Bryant E, Larholt R, Sampson A, Rudnick S. Recombinant human erythropoietin in the treatment of the anemia associated with human immunodeficiency virus infection and zidovudine therapy: overview of four clinical trials. Ann Intern Med. 1991;117:739-48. | 1991 |
| Ettinger DS, Finkelstein DM, Abeloff MD, Ruckdeschel JC, Aisner SC, Eggleston JC. A randomized comparison of standard chemotherapy versus alternating chemotherapy and maintenance versus no maintenance therapy for extensive-stage small cell lung cancer: a phase III study of the Eastern Cooperative Oncology Group. J Clin Oncol.1990;8:230-40. | 1990 |
| Aisner SC, Finkelstein DM, Ettinger DS, Abeloff MD, Ruckdeschel JC, Eggleston JC. The clinical significance ofvariant-morphology small cell carcinoma of the lung. J Clin Oncol. 1990;8:402-8. | 1990 |
| Blanchard CG, Labrecque MS, Ruckdeschel JC, Blanchard EB. Physician behaviors, patient perceptions and patient characteristics as predictors of satisfaction of hospitalized adult cancer patients. Cancer. 1990;65:186-92. | 1990 |
Braun MA, Killam DA, Remick SC, Ruckdeschel JC. Lung cancer in patients seropositive for human
immunodeficiency virus. Radiology. 1990;175:341-3 | 1990 |
| Remick SC, Diamond C, Migliozzi JA, Solis O, Wagner H, Haase RF, Ruckdeschel JC. Primary central nervous system lymphoma (PCL) in patients with and without AIDS. A retrospective analysis and review of the literature. Medicine. 1990;69(6):345-60. | 1990 |
| Nelles WB, Blanchard CG, McCaffrey RJ, Ruckdeschel JC. Social supports and breast cancer: a review. J Psychosoc Oncol. 1991;9(2):21-34. | 1990 |
| Ettinger DS, Finkelstein DM, Abeloff MD, Chang YC, Smith TJ, Oken MM, Ruckdeschel JC. Phase II study of nmethylformamide (NSC 3051) and spirogermanium (NSC 192965) in the treatment of advanced small cell lung cancer. Invest New Drugs. 1990;9(2):183-85. | 1990 |
| Ruckdeschel JC. Attempts to enhance locoregional control of cancer by radiotherapy, phototherapy and combined modality therapy [invited review]. Curr Opin Oncol. 1989;1:231-5. | 1989 |
| Bonomi PD, Finkelstein DM, Ruckdeschel JC, Blum RH, Green MD, Mason B, Hahn R, Tormey DC, Harris J, Comis R, Glick J. Combination chemotherapy versus single agents followed by combination chemotherapy in stageIV non-small cell lung cancer (NSCLC): an Eastern Cooperative Oncology Group study. J Clin Oncol. 1989;7:1602-13. | 1989 |
| Ettinger DS, Finkelstein DM, Donehower RC, Chang AYC, Greene M, Blum R, Hahn RG, Ruckdeschel JC. A phase II study of n-methylformamide, spirogermanium and 4-demethoxydaunorubicin in the treatment of non-small cell lung cancer (EST 3583). An ECOG Study. Med Ped Oncol. 1989;17:197-201. | 1989 |
| Finkelstein DM, Cassileth BR, Bonomi PD, Ruckdeschel JC, Ezdinli EZ, Wolter JM. A pilot study of the functional living index-cancer (FLIC) scale for the assessment of quality of life for metastatic lung cancer patients: an Eastern Cooperative Oncology Group study. Am J Clin Oncol. 1988;11:630-33. | 1988 |
| Blanchard CG, Labrecque MS, Ruckdeschel JC, Blanchard EB. Information and decision-making preferences of hospitalized adult cancer patients. Soc Sci Med. 1988;27:1139-45. | 1988 |
| Ruckdeschel JC, Carney DN, Oie H, Russell EF, Gazdar AF. In vitro chemosensitivity of human lung cancer cell lines. Cancer Treat Rep. 1987;71:697-704. | 1987 |
| Trump DL, Elson P, Borden EC, Harris J, Tuttle R, Whisnant JK, Oken M, Carignan JR, Ruckdeschel JC, Davis TE. High dose lymphoblastoid interferon in advanced renal cell carcinoma. An Eastern Cooperative Oncology Group study. Cancer Treat Rep. 1987;71:165-69. | 1987 |
| Baker RR, Ettinger DS, Ruckdeschel JC, Eggleston JC, McKneally MF, Abeloff MD, Woll JE, Adelstein DJ. The role of surgery in the management of selected patients with small cell carcinoma of the lung. J Clin Oncol.1987;5:697-702. | 1987 |
| Blanchard CG, Ruckdeschel JC, Labrecque MS, Frisch S, Blanchard EB. The impact of a designated cancer unit on house staff behaviors toward patients. Cancer. 1987;60:2348-54. | 1987 |
| Ruckdeschel JC, Finkelstein DM, Ettinger DS, Creech RA, Mason RC, Joss BA, Vogl S A randomized trial of the four most active regimens for metastatic non-small cell lung cancer. J Clin Oncol. 1986;4:14-22. | 1986 |
| Finkelstein DM, Ettinger DS, Ruckdeschel JC. Long-term survivors in metastatic non-small cell lung cancer: an Eastern Cooperative Oncology Group study. J Clin Oncol. 1986;4:702-9. | 1986 |
| Blanchard CG, Ruckdeschel JC, Fletcher BA, Blanchard EB. The impact of oncologists behavior on patient satisfaction with morning rounds. Cancer. 1986;58:387-93. | 1986 |
| Cohen RE, Blanchard EB, Ruckdeschel JC, Smolen RC. Prevalence and correlates of post-treatment and anticipatory nausea and vomiting in cancer chemotherapy. J Psychosom Res. 1986;30:643-54. | 1986 |
| Funa K, Dawson N, Jewett PB, Agren H, Ruckdeschel JC, Bunn Jr PA, Gazdar AF. Automated fluorescent analysis for drug-induced cytotoxicity assays. Cancer Treat Rep. 1986;70:1147-51. | 1986 |
| Rodichok LD, Ruckdeschel JC, Harper GR, Cooper G, Prevosti L, Fernando L, Baxter DH. Early detection and treatment of spinal epidural metastases: the role of myelography Ann Neurol. 1986;20:696-702. | 1986 |
| Mulshine J, Glatstein E, Ruckdeschel JC Treatment of non-small cell lung cancer [invited review]. J Clin Oncol.1986;11:1704-15. | 1986 |
| Blanchard CG, Ruckdeschel JC. Psychosocial aspects of cancer in adults: implications for teaching medical students. J Cancer Educ. 1986;1:237-48. | 1986 |
| Ruckdeschel JC, Day R, Weissman CH, Stolbach LL, Creech RH. Chemotherapy for metastatic non-small cell bronchogenic carcinoma: cyclophosphamide, doxorubicin and etoposide versus mitomycin-vinblastine (EST 2575, generation IV). J Clin Oncol. 1985;3:72-9. | 1985 |
| Ruckdeschel JC, Finkelstein D, Creech RH, Mason BA. Chemotherapy for metastatic non-small cell bronchogenic carcinoma: EST 2575, general V: a randomized comparison of four cisplatin-containing regimens. J Clin Oncol. 1985;3:72-9. | 1985 |
| Vogl SE, Camacho F, Berenzweig M, Ruckdeschel JC. Chemotherapy for esophageal cancer with mitoguanazone, methotrexate, bleomycin and cisplatin. Cancer Treat Rep. 1985;69:21-3. | 1985 |
| O’Donnell MR, Ruckdeschel JC, Baxter D, McKneally MF, Caradonna R, Horton J. Intensive induction chemotherapy for small cell anaplastic carcinoma of the lung. Cancer Treat Rep. 1985;69:571-5. | 1985 |
| Bonomi P, O’Reilly W, Vogl SE, Ruckdeschel JC, Stolbach L, Bunting N, Creech RH. Intensive induction treatment of small cell bronchogenic carcinoma with cyclophosphamide, methotrexate and etoposide. Cancer Treat Rep.1985;69:1007-9. | 1985 |
| Ettinger DS, Finkelstein DM, Harper GR, Ruckdeschel JC, Chang AY, Camacho FJ, Marsh JC, Silber R, Wolter JM. Phase II study of mitoxantrone, aclarubicin and diaziquinone in the treatment of non-small cell lung carcinoma: an Eastern Cooperative Oncology Group study. Cancer Treat Rep. 1985;69:1033-4. | 1985 |
| Ahles T, Ruckdeschel JC, Blanchard EB. Cancer-related pain. I: prevalence in an outpatient setting as a function of stage of disease and type of cancer. J Psychosom Res. 1984;28:115-9. | 1984 |
| Zimmerman MS, Ruckdeschel JC, Hussain M. Chemotherapy-induced interstitial pneumonitis during treatment of small cell anaplastic lung cancer. J Clin Oncol. 1984;2:396-405. | 1984 |
| Ahles T, Ruckdeschel JC, Blanchard EB. Cancer-related pain. II: assessment with visual analogue scales. J Psychosom Res. 1984;28:121-4. | 1984 |
| Creech RH, Tritchler D, Ettinger DS, Ferraro JA, Ruckdeschel JC, Vogl SE, Woll J. Phase II study of PALA amsacrine, teniposide and zinostatin in small cell lung carcinoma (EST-2579). Cancer Treat Rep. 1984;68:1183-4. | 1984 |
| Spiers ASD, Ruckdeschel JC, Horton J. Effectiveness of pentostatin (2’-deoxyoformycin) in refractory lymphoid neoplasms. Scand J Haematol. 1984;32:130-4. | 1984 |
| Ettinger SD, Day R, Ferraro JA, Ruckdeschel JC, Woll JE, Vogl SE. A phase II study of AMSA (NSC 249992) and neocarzinostatin (NSC 157365) in non-small cell bronchogenic carcinoma: an Eastern Cooperative Oncology Group study. Am J Clin Oncol. 1983;6:167-70. | 1983 |
| Ahles TA, Blanchard EB, Ruckdeschel JC. The multidimensional nature of cancer-related pain. Pain. 1983;17:277-88. | 1983 |
| Blanchard CB, Ruckdeschel JC, Blanchard EB, Arena JG, Saunders NL, Malloy ED. Interactions between oncologists and patients during rounds. Ann Intern Med. 1983;99:694-9. | 1983 |
| Arsenau JC, Wolter JM, Juperminc M, Ruckdeschel JC. A phase II study of bruceantin (NSC-165, 563) in advanced malignant melanoma. Invest New Drugs. 1983;1:239-42. | 1983 |
| Cohen RE, Ruckdeschel JC, Blanchard CG, Rohrbaugh M, Horton J. Attitudes towards cancer. II: a comparative analysis of cancer patients, medical students, medical residents, physicians and cancer educators. Cancer. 1982;50:1218-23. | 1982 |
| Ruckdeschel JC, Lea JW, Brown S, Horton J. Content-bias in the neoplastic-related items of the national board of medical examiners part II examination. Med Pediatr Oncol. 1982;10:269-74. | 1982 |
| Blanchard C, Ruckdeschel JC, Cohen RE, Horton J, McSharry J, Shaw E. Attitudes towards cancer. I: the impact of a comprehensive oncology course on second year medical students. Cancer. 1981;47:2756-62. | 1981 |
| Lunia SL, Ruckdeschel JC, McKneally MF, Killam E, Baxter D, Kellar S, Ray P, McIlduff J, Lininger L, Chodos R, Horton J. Non-Invasive evaluation of mediastinal metastases in bronchogenic carcinoma: a prospective comparison of chest radiography and gallium-67 scanning. Cancer. 1981;47:672-9. | 1981 |
| Rodichok LD, Harper GR, Ruckdeschel JC, Price A, Roberson G, Barron KD, Horton J. Early diagnosis of spinal epidural metastases. Am J Med. 1981;70:1181-7. | 1981 |
| Ruckdeschel JC, Mehta CR, Salazar OM, Cohen M, Vogl S, Koons LS, Lerner H. Chemotherapy of inoperable non-small cell bronchogenic carcinoma. Cancer Treat Rep. 1981;65:965-72. | 1981 |
| Ruckdeschel JC, Mehta CR, Salazar OM, Cunningham TJ, Creech RH, Sponzo RW. Chemotherapy for metastatic non-small cell bronchogenic carcinoma: EST 2575 generation III, HAM vs CAMP. Cancer Treat Rep. 1981;65:959-63. | 1981 |
| Brandman J, Ruckdeschel JC, O’Donnell M, Horton J. Rapid tumor necrosis leading to serious pulmonary infections in patients treated intensively for small cell cancer of the lung. N Y State J Med. 1981;81:1332-4. | 1981 |
| Ruckdeschel JC, McKneally MF, Baxter DH, Devore C, Kellar S, Killam D, Caradonna R, Sedransk N, McIlduff J, Horton J. Regional immunotherapy has a detrimental effect on the response to combined irradiation and chemotherapy in locally advanced non-small cell bronchogenic carcinoma. Cancer Immunol Immunother. 1981;11:277-82. | 1981 |
| Ferraro JA, Horton J, Weissman C, Ruckdeschel JC, O’Donnell M, Ludlum D. Treatment of advanced colorectal carcinoma with AMSA. Cancer Treat Rep. 1981;65:345-7. | 1981 |
| Lempert N, MacDowell RT, Karmody A, Knight E, Cunningham TJ, Sponzo R, Horton J, Ruckdeschel JC. Vascular access for cancer chemotherapy. Cancer. 1979;43:1934-6. | 1979 |
| Caradonna R, Paladine W, Ruckdeschel JC, Goldstein JC, Olsen JE, Jaski JW, Silvers SA, Hillinger S, Horton J. Methotrexate, bleomycin and high dose cis-platinum for advanced epidermoid carcinoma of the head and neck Cancer Treat Rep. 1979;63:489-91. | 1979 |
| Ruckdeschel JC, Baxter DH, McKneally MR, Killan DA, Lunia SL, Horton J. Sequential radiotherapy and adriamycin in the management of bronchogenic carcinoma: the question of additive toxicity. Int J Radiat Oncol Biol Phys. 1979;5:1323-8. | 1979 |
Ruckdeschel JC, Lininger L, Brzyski H, Miani M, Becker J. Serial quantitation of in vitro lymphocyte
responsiveness to Concanavalin-A. Transplantation. 1979;28(3):203-6. | 1979 |
| Ruckdeschel JC, Caradonna R, Paladine WJ, Hillinger SM, Horton J. Small cell anaplastic carcinoma of the lung: changing concepts and emerging problems. CA Cancer J Clin. 1979;29:84-95. | 1979 |
| Ruckdeschel JC, Schimpff SC, Smyth AC, Mardiney Jr MR. Correlation of susceptibility to herpes zoster with impaired cell associated immunity to the varicella-zoster virus in patients with hodgkin’s disease. Am J Med. 1977;62:77-85. | 1977 |
| Ruckdeschel JC, Doukas J, Drake WP, Mardiney Jr MR. Application of laser cytometry to the analysis of immunologically induced in vitro lymphocyte blastogenesis. Transplantation. 1977;23:396-403. | 1977 |
| Doukas J, Ruckdeschel JC, Mardiney Jr MR. Quantitative and qualitative analysis of human peripheral lymphocyte proliferation to specific antigen in vitro by use of the helium neon laser. J Immunol Methods. 1977;15:229-38. | 1977 |
| Hahn DM, Schimpff SC, Ruckdeschel JC, Wiernik PH. Single-agent therapy for renal cell carcinoma: CCNU, vinblastine, thiotepa, or bleomycin. Cancer Treat Rep. 1977;61(8):1585-7. | 1977 |
| Ruckdeschel JC, Mardiney Jr MR. The demonstration of cell associated immunity to viruses. In vitro lymphocyte responsiveness to varicella-zoster antigen. J Immunol Methods. 1976;13:131-43. | 1976 |
| Graziano KD, Ruckdeschel JC, Mardiney Jr MR. Cell associated immunity to measles (rubeola): the demonstration of in vitro lymphocyte tritiated thymidine incorporation in response to measles complement fixation antigen. Cellular Immunol. 1975;15:247-359. | 1975 |
| Ruckdeschel JC, Graziano, KD, Mardiney Jr MR. Additional evidence that the cell associated immune system is the primary host defense against measles (rubeola). Cell Immunol. 1975;17:11-18. | 1975 |
| Ruckdeschel JC, Chang P, Martin RG, Byhardt RW, O’Connell MJ, Sutherland JC, Wiernik PH. Radiation-related pericardial effusions in patients with Hodgkin’s disease. Medicine (Baltimore). 1975;54:245-59. | 1975 |
| Byhardt RW, Brace K, Ruckdeschel JC, Chang P, Martin RW, Wiernik PH. Dose and treatment factors in radiation related pericardial effusion associated with the mantle technique for hodgkin’s disease. Cancer. 1975;35:795-802. | 1975 |
| Martin RW, Ruckdeschel JC, Chang P, Byhardt RW, Bouchard P, Wiernik PH. Radiation-related pericarditis. Am J Cardiol. 1975;35:216-20. | 1975 |
| Dummire C, Ruckdeschel JC, Mardiney Jr MR. Suppression of in vitro lymphocyte responsiveness to PPD by measles virus: a re-exploration of the phenomenon. Cell Immunol. 1975;20:205-17. | 1975 |
| Drake WP, Porkorney DR, Ruckdeschel JC, Levy CC, Mardiney Jr MR A white blood cell ribonuclease assay forthe monitoring of malignancy. J Natl Cancer Inst. 1975;54:1475-78. | 1975 |
| Ruckdeschel JC, Kramarsky B, Mardiney Jr MR. Mycoplasma contamination of membrane associated measles antigens. Inability to demonstrate in vitro lymphocyte responsiveness to measles. Cell Immunol. 1975;20:110-16. | 1975 |
| Ruckdeschel JC, Codish SD, Stranahan A, McKneally MF. Postoperative empyema improves survival in lung cancer. Documentation and analysis of a natural experiment. N Engl J Med. 1972;287:1013-7. | 1972 |
| Ruckdeschel JC, Peters T, Lee KT. Fibrinogen catabolism in rats fed thrombogenic diets. Atherosclerosis. 1972;16:277-85. | 1972 |
| Sklarin NT, Wiernik PH, Grove WR, Benson L, Mittelman A, Maroun JA, Steward JA, Robert F, Doroshow JH, Rosen PJ, Jolivet J, Ruckdeschel JC, Robert NJ, Velez-Garcia E, Bergsagel DE, Panasci LC, van der Merwe AM, Longueville JJ, Leiby J. A phase II trial of CI-921 in advanced malignancies. Invest New Drugs. 1992;10:309-12. | |
| Albrecht TL, Penner LA, Cline RJ, Eggly SS, Ruckdeschel JC, Studying the process of clinical communication: issues of context, concepts, and research directions. Journal of health communication, 2009;14 Suppl 1:47-56 | |
| Quinn GP, Jacobsen PB, Albrecht TL, Ellison BA, Newman NW, Bell M, Ruckdeschel JC, Real-time patient satisfaction survey and improvement process. Hospital topics, 2004 Summer;82(3):26-32 | |
| Albrecht TL, Penner LA, Ruckdeschel JC, Understanding patient decisions about clinical trials and the associated communication process: a preliminary report. Journal of cancer education : the official journal of the American Association for Cancer Education, 2003 Winter;18(4):210-4 | |
| Chirikos TN, Ruckdeschel JC, Krischer JP, Economic analysis of cancer treatment costs: another tool for oncology managers. The Journal of oncology management : the official journal of the American College of Oncology Administrators, 2001 Jul-Aug;10(3):11-7 | |
| Remick SC, Sedransk N, Haase R, Craffey M, Subramanian N, Dowlati A, Nazeer T, Ramnes C, Blanchard C, Mastrianni D, Balducci L, Horton J, Ruckdeschel JC, Oral combination chemotherapy in the management of AIDS-related lymphoproliferative malignancies. Drugs, 1999;58 Suppl 3:99-107 | |
| Larson GP, Zhang G, Ding S, Foldenauer K, Udar N, Gatti RA, Neuberg D, Lunetta KL, Ruckdeschel JC, Longmate J, Flanagan S, Krontiris TG, An allelic variant at the ATM locus is implicated in breast cancer susceptibility. Genetic testing, 1997-1998;1(3):165-70 | |
| Ruckdeschel JC, Albrecht TL, Blanchard C, Hemmick RM, Communication, accrual to clinical trials, and the physician-patient relationship: implications for training programs. Journal of cancer education : the official journal of the American Association for Cancer Education, 1996 Summer;11(2):73-9 | |
| Scott F, Cuttitta F, Treston AM, Avis I, Gupta P, Ruckdeschel J, Kelly K, Piantadosi S, Tockman M, Mulshine J, Prospective trial evaluating immunocytochemical-based sputum techniques for early lung cancer detection: assays for promotion factors in the bronchial lavage. Journal of cellular biochemistry. Supplement, 1993;17F:175-83 | |
Book Chapter |
| Ruckdeschel JC At the Core of Oncology The Art and Science of Oncology. Boston (MA): Aspatore Books; 2007, pp33-44 | |
Ruckdeschel JC
Abeloff M, Armitage J, and Niederhuber J Lung cancer Clinical Oncology. Philadelphia: Churchill-Livingstone; 2004. p.1649-743. | |
Ruckdeschel JC
Abeloff M, Armitage J, and Niederhuber J Spinal cord compression Clinical Oncology. Philadelphia: Churchill-Livingstone; 2004. p.1063-71. | |
Book |
| Helft PR, Albrecht TL, Back A, Ruckdeschel JC. Challenges to physician communication about treatment options to patients. ASCO Educational Book Alexandria: American Society of Clinical Oncology; 2006 | |
| Ruckdeschel JC Myths and facts about lung cancer. What You Need to Know Melville (NY): PRR Publishers; 2004. | |
| Ruckdeschel JC Update in the management of lung cancer New York (NY): RogersMIS. 2004;3(2) | |
| Ninane V, LePechoux C, Curran W, Furuse K, Liptay M, Meert AP, Paesmans M, Rami-Porta R, Roelandts R, Ruckdeschel JC, Sculier JP, Senan S, Smit EF Critical factors for patient management Lung Cancer. 2003;42(suppl):57-8. | |
| Alberts WM, Bepler G, Hazelton T, Ruckdeschel JC, Williams Jr JH Practice organization Chest. 2003;123(suppl 1):2202-5. | |
Ruckdeschel JC, Greene J, Sommers KE, Fields KK
Kufe DW, Holland JF, Frei E, Respiratory complications of cancer and its treatment Cancer Medicine 6. Hamilton (ON); Lewiston (NY) [distributor]: BC Decker. 2003. | |
Albrecht TA, Blanchard CG, Ruckdeschel JC, Coovert MA
Brashers D, Goldsmith D, and Lammers L The mediating role of communication in cancer treatment decision making Communication in the management of health and illness. Manwah (NJ): Lawrence Erlbaum & Associates. In press. | |
| Robinson LA, Wagner H, Ruckdeschel JC Lung cancer guidelines, treatment of stage IIIA non-small cell lung cancer Chest. 2003;123(suppl 1): 3325-75. | |
| Ruckdeschel JC Myths and facts about lung cancer: What You Need to Know Melville (NY): PRR Publishers; 2002. | |
Ruckdeschel JC, Jablons D
Kirkwood JM, Lotze MT, Yasko JM Malignant effusions of the chest Cancer Therapeutics. 4th ed. Philadelphia: Current Medicine; 2001. | |
Ruckdeschel JC, Robinson L
Berger, Portenoy, Weissman Management of pleural and pericardial effusions Lung cancer; principles and practice of palliative care and supportive oncology. Philadelphia: Lippincott,Williams & Wilkins. In press 2001 | |
| Simon G, Ginsberg R, Ruckdeschel JC Small cell lung cancer Chest Surg Clin N Am. 2001;11(1):165-8. | |
Ruckdeschel JC
Ratain MJ, Tempero M, Skosey C Intrapleural therapy Oncology therapeutics: a quick reference guide. Philadelphia: WB Saunders; 2000 | |
Blanchard C, Albrecht T, Ruckdeschel JC
Bader, Cooper, DeNour Patient family communication with physicians Cancer and the family. 2nd ed. West Sussex (England): John Wiley & Sons, Ltd; 2000. p.477-95. | |
| Ruckdeschel JC Myths and facts about lung cancer: What You Need to Know Melville (NY): PRR Publishers; 1999. | |
| Yanes B, Bonomi PD, Curran Jr WJ, Ginsberg RJ, Khuri FR, Ruckdeschel JC, Weiland JE Advances in lung cancer management: 1997 Miami Valley hospital lung conference [monograph] Bristol Myers Squibb, 1998 | |
Tockman M, Ruckdeschel JC, Mulshine J
Jett J The early detection of second primary lung cancers by sputum immunostaining Current clinical trials in thoracic oncology - what the chest physician needs to know. 1998;2(1):3,8-9. | |
Ruckdeschel JC
Abeloff M, Armitage J, Lichter A, Niederhuber J Spinal cord compression Clinical Oncology. 2nd ed. New York: Churchill Livingstone; 1999. p.811-9. | |
| Ruckdeschel JC Chemotherapy for lung cancer: new agents with significant benefit Primary Care & Cancer. 1998;18(5):26-32. | |
Mackey CS, Ruckdeschel JC
Sullivan P, Guilford AM Lung cancer Swallowing Intervention in Oncology. San Diego: Singular Publishing; 1999. p.117-33. | |
| Ruckdeschel JC, Aisner J, Evans W, Gandara D, Green M, Holmes EC, Ihde DC, Johnson DH, Sause WT, Wagner Jr H Commentary and review of presentations on lung cancer [monograph] Bristol Myers Squibb, 1998 | |
Ruckdeschel JC
Kirkwood JM, Lotze MT, Yasko JM Malignant effusions in the chest Current Cancer Therapeutics, 3rd ed. New York: Churchill Livingstone; 1998. p.324-8. | |
Ruckdeschel JC
Jett J A prospective randomized trial of bleomycin vs doxycycline vs talc for the intrapleural treatment of malignant pleural effusions. Current clinical trials in thoracic oncology - what the chest
physician needs to know. 1997;1(3). | |
| Ruckdeschel JC, Aisner J, Ettinger D, Jett J, Wagner H Current approaches to managing patients with small cell lung cancer [monograph] Smith Kline Beecham, 1997 | |
Garland LL, Ruckdeschel JC, Wagner Jr H, Williams Jr C, Shaw G, Antonia S, Heise M, Hilstro J, Cantor A
Johnson, Klastersky Single agent paclitaxel as second-line chemotherapy for resistant, metastatic non-small cell lung cancer Taxanes in lung cancer therapy. New York: Marcel Dekker, Inc.; 1998. p.117-26. | |
Ruckdeschel JC
Roth JA, Cox JD, Hong WK Preoperative and postoperative adjunctive therapy for resectable non-small cell lung cancer Lung Cancer. 2nd ed. Boston: Blackwell Scientific; 1997. p.207-16. | |
| Bonomi P, Ruckdeschel JC New approaches in the treatment of stage IV non-small cell lung cancer [monograph] Bristol Myers Squibb, 1997. | |
| Ruckdeschel JC Editorial overview: lung and mediastinum Curr Opin Oncol. 1997;9(2):147-8 | |
Antonia S, Robinson LA, Ruckdeschel JC, Wagner H
Balducci, Lyman, Ersher Lung cancer Comprehensive geriatric oncology. 2nd ed. London: Harwood Academic Publishers; 1997. p.613-30. | |
| Ruckdeschel JC Treating lung cancer Coping. 1997;38-9 | |
Robinson L, Ruckdeschel JC
Berger, Portenoy, Weissman Management of pleural and pericardial effusions Lung cancer: principles and practice of supportive oncology. Philadelphia: JB Lippincott; 1998. p.327-52 | |
| Ruckdeschel JC Combined modality therapy of non-small cell lung cancer Semin Oncol. 1997;24(4):429-39 | |
| Ruckdeschel JC, Robinson L Malignant pleural effusions: questions and controversies [monograph] Bristol Myers Squibb, 1997. | |
Ruckdeschel JC
Semendinger Breaking clinical and administrative barriers The challenge of health care leadership. Chicago: AHA Publishing; 1997. p.51-68. | |
| Ruckdeschel JC, Wagner H, Robinson L Cáncer de Pulmón Localmente Avanzado [Locally Advanced Lung Cancer] (Spanish) Revista argentina cancerología. 1996;24(2):90-2 | |
| Ruckdeschel JC, Wagner H, Robinson L Locally advanced lung cancer: controversies in management Advances in Oncology. 1996;12(3):22-8 | |
| Ruckdeschel JC, Wagner H, Robinson L Locally advanced lung cancer - controversies in management ASCO Educational Book, 1996. | |
| Ruckdeschel JC Malignant pleural effusion: a cost-effectiveness analysis of pleurodesis [monograph] Bristol Myers Squibb, 1996. | |
Ruckdeschel JC
Kirkwood JM, Lotze MT, Yasko JM Malignant effusions in the chest Current cancer therapeutics. 2nd ed. Philadelphia: Churchill-Livingstone; 1996. p.304-8. | |
| Ruckdeschel JC, Aisner J, Ettinger DS, Johnson DH, Wagner H Small cell lung cancer [monograph] Bristol Myers Squibb, 1995. | |
| Ruckdeschel JC Introduction: LCSG - the final analysis Chest. 1994;106(6):279s. | |
Blanchard C, Ruckdeschel JC, Albrecht T
Bader, Cooper, DeNour Patient-family communication with physicians Cancer and the family. West Sussex : John Wiley & Sons; 1996. p.369-87. | |
Wagner H, Ruckdeschel JC
Reintgen D, Clark RA Screening, early detection and early intervention strategies for cancer of the respiratory system (lung and bronchus) Cancer screening. St. Louis: Mosby Year Book; 1995. p.118-49. | |
Moores D, Ruckdeschel JC
Roth J, Ruckdeschel J, Weisenburger T Pleural effusions in patients with malignancy Thoracic Oncology II. Philadelphia: WB Saunders; 1995. p.556-66. | |
Williams C, Ruckdeschel JC
Roth J, Ruckdeschel J, Weisenburger T Management of disseminated non-small cell lung cancer Thoracic Oncology II. Philadelphia: WB Saunders; 1995. p.181-7. | |
Ruckdeschel JC
Roth J, Weisenburger T Lung cancer: an overview Thoracic Oncology II. Philadelphia: WB Saunders; 1995. p.3-4. | |
| Ruckdeschel JC Future directions in non-small cell lung cancer-a personal view Lung cancer. 1995;12(2):s147- 52. | |
| Ruckdeschel JC Current status and future role of carboplatin [monograph] Bristol-Myers Squibb, 1994. | |
Ruckdeschel JC, Robinson LA
Pass H, Mitchell D, Johnson A, Turrisi J Non-small cell lung cancer: surgery and postoperative adjuvant chemotherapy Lung cancer: principles & practice. Philadelphia: JB Lippincott; 1996. P.839-49. | |
Ruckdeschel JC
Rakel R Carcinoma of the lung current therapy Conn’s current therapy. Philadelphia: WB Saunders; 1994. p.156-63. | |
Ruckdeschel JC
Abeloff M, Armitage J, Lichter A, Niederhuber J Spinal cord compression due to cancer: early diagnosis and treatment Clinical oncology. New York: Churchill Livingstone; 1995. p. 619-28. | |
| Ruckdeschel JC The future role of carboplatin Semin Oncol. 1994;21(5):114-8. | |
Ruckdeschel JC
Roth J, Cox J, Hong WK Preoperative and postoperative adjunctive therapy for resectable non-small cell lung cancer Lung cancer. Boston: Blackwell Scientific Publications; 1993. p. 239-51. | |
| Wagner H, Ruckdeschel JC Treatment of locally advanced and metastatic non-small cell lung cancer Advances in Oncology. 1993;9(5):22-9. | |
| Ruckdeschel JC The role of standard dose etoposide in the management of non-small cell lung cancer Semin Oncol. 1992;19(6):39-44. | |
| Ruckdeschel JC Lung cancer - 1993 Mediguide to oncology. 1994;14(1):1-8. | |
| Remick SC, Wagner H, Ruckdeschel JC Management of the patient with HIV-associated lymphomas and hodgkins disease AIDS reader. 1991;1:204-13. | |
Ruckdeschel JC A comparative overview of non-small cell lung cancer: 1980 v 1991 Lung cancer.
1993;9(suppl):15-24. | |
| Moffett MJ, Ruckdeschel JC Bleomycin and tetracycline in malignant pleural effusions Semin Oncol.1992;19(suppl):59-62. | |
| Ruckdeschel JC Current surgical approach to non-small cell lung cancer” by McCormack P [invited commentary] Oncology. 1991;5(11):44-6. | |
Holmes EC, Ruckdeschel JC
Pass H Postoperative chemotherapy for non-small cell lung cancer Chest Clinics of North America. 1991;1(1):89-97. | |
Ruckdeschel JC, Holmes EC
Pass H Preoperative chemotherapy for locally advanced non-small cell lung cancer Chest Clinics of North America. 1991;1:1-12. | |
| Ruckdeschel JC Malignant pleural effusions: recent advances in diagnosis and management Bristol-Myers Squibb; 1992. | |
| Ruckdeschel JC Etoposide in the management of non-small cell lung cancer Cancer. 1991;67(suppl):250. | |
Blanchard CG, Ruckdeschel JC
Roth J, Ruckdeschel J, Weisenburger T Quality of life Textbook of Thoracic Oncology. Philadelphia, PA: WB Saunders; 1989. p. 681-6. | |
Mulshine J, Ruckdeschel JC
Roth J, Ruckdeschel J, Weisenburger T The role of chemotherapy in the management of disseminated non-small cell lung cancer Textbook of thoracic oncology. Philadelphia, PA: WB Saunders; 1989. p 220-8. | |
Ruckdeschel JC
Roth J, Ruckdeschel J, Weisenburger T Lung cancer: an introduction Textbook of Thoracic Oncology. Philadelphia, PA: WB Saunders; 1989. p 2-5. | |
| Ruckdeschel JC Clinical advances in management of malignant pleural effusions J Crit Illn. 1988. | |
Ruckdeschel JC
Bitram J, Golomb H Chemotherapy of disseminated non-small cell lung cancer Lung cancer: a comprehensive treatise. New York, NY: Grune & Stratton; 1988. p 233-41. | |
| Ruckdeschel JC Management of malignant pleural effusions Semin Oncol. 1988;15(3 suppl 3):24-8. | |
Ruckdeschel JC
Kimura K, Ota K, Heberman RB, Takita H Chemotherapy of non-small cell lung cancer Cancer chemotherapy: challenges for the future, vo. 2. pp 202-209, Eds. K. Kimura, K. Ota, R.B. Heberman, H. Takita. Tokyo: Excerpta Medica; 1987. p 202-209. | |
Ruckdeschel JC, Oie HK, Gazdar AF
Hansen HH,Nijhoff M In vitro characterization of non-small cell lung cancer Lung cancer: basic and clinical aspects. Boston: Kluwer; 1986. p. 49-59. | |
| Muggia FM, Goldin A, Ruckdeschel JC New drugs in lung cancer Proceedings of the 4th Mediterranean Congress of Chemotherapy; 1984 Oct 19-25; Rhodes, Greece. Chemioterapia. 1984;4(2 Suppl):1138-9. | |
Ruckdeschel JC, Blanchard CG, Blanchard EB
Hurst W Direct measurement of physician behavior as a potential method of evaluating medical education Teaching internal medicine. 1984. | |
Ruckdeschel JC, Balint J, Gross P, Laufer F
Hurst W Instructional costs for full-time faculty in an academic department of internal medicine Teaching internal medicine. 1984. | |
Ruckdeschel JC
Schimpff S, Moossa AR, Robson MC Immunotherapy of Human Cancer: An Overview Comprehensive Textbook of Oncology. Baltimore: Willliams and Wilkins Publishers; 1984. | |
| Ruckdeschel JC Lung cancer - mediguide to oncology 1981;1(6) | |
| Ruckdeschel JC Diagnosis and management of small cell anaplastic (oat cell) cancer of the lung Current concepts in oncology. 1979;1:18-24. | |
Ruckdeschel JC, Lininger L, Brzyski H, Miani M, Becker J
Baum S Re-analysis of in vitro lymphocyte blastogenesis using the laser cytometry assay Experimental hematology today. Farmington, CT: Karger; 1979.p.123-8. | |
Book Review |
| Ruckdeschel JC IASLC proceedings - future directions in non-small cell lung cancer: a continuing perspective [review] Oncology. 1998;12(2):90-6. | |
| Ruckdeschel JC Comprehensive textbook of oncology [review] J Natl Cancer Inst. 1992;84:1596-7. | |
Ruckdeschel JC
Arriagada R, LeChevalier Treatment modalities in lung cancer J Natl Cancer Inst. 1989; 8:633-4. | |
Editorial Commentary |
| Ruckdeschel JC. Is chemotherapy for metastatic non-small cell lung cancer “worth it?” J Clin Oncol. 1990;8:1293-6. | 1990 |
| Ruckdeschel JC. Whither screening for lung cancer [editorial]. J Natl Cancer Inst. 1988;80:78-9. | 1988 |
| Ruckdeschel JC We have met the enemy . . . and they is us! [commentary] Curr Opin Oncol. 1996;8:103-5. | |
| Ruckdeschel JC The cost of success in the treatment of thoracic malignancies [commentary] Curr Opin Oncol. 1995;7:131-3. | |
| Ruckdeschel JC Early diagnosis of lung cancer [editorial] Clinical Cancer Briefs. 1981;2:2. | |
Letter to the Editor |
| Mardiney Jr MR, Ruckdeschel JC. Inhibition of in vitro lymphocyte response by measles virus antigen: a reply [letter]. Cell Immunol. 1977;28:229. | 1977 |
| Ruckdeschel JC Chemotherapy in metastatic lung cancer: Reply [letter] J Clin Oncol. 1986;4:1151-2. | |
| Ruckdeschel JC Amantadine and pulmonary peripheral airways [letter] Ann Int Med. 1977;86:369-70. | |
| Ruckdeschel JC, Wiernik PH Reactions to radiation therapy [letter] N Engl J Med. 1975;293:668-9. | |
| Ruckdeschel JC Tumor registries [letter] JAMA. 1973;266-72 | |
Clinical Trial |
| Albrecht TL, Eggly SS, Gleason ME, Harper FW, Foster TS, Peterson AM, Orom H, Penner LA, Ruckdeschel JC, Influence of clinical communication on patients' decision making on participation in clinical trials. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008 Jun 1;26(16):2666-73 | 2008 |
| Jacobsen PB, Meade CD, Stein KD, Chirikos TN, Small BJ, Ruckdeschel JC, Efficacy and costs of two forms of stress management training for cancer patients undergoing chemotherapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002 Jun 15;20(12):2851-62 | 2002 |
| Kilbridge KL, Cole BF, Kirkwood JM, Haluska FG, Atkins MA, Ruckdeschel JC, Sock DE, Nease RF Jr, Weeks JC, Quality-of-life-adjusted survival analysis of high-dose adjuvant interferon alpha-2b for high-risk melanoma patients using intergroup clinical trial data. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002 Mar 1;20(5):1311-8 | 2002 |
| Remick SC, Chmura M, Bromberg C, Sporn J, Healey B, Hilstro J, DeConti RC, Horton J, Ruckdeschel JC, Harper GR, Concurrent 72-hour continuous infusion of etoposide and cisplatin in metastatic breast cancer. American journal of clinical oncology, 1996 Apr;19(2):125-31 | 1996 |
| Antonia SJ, Wagner H, Williams C, Alberts M, Hubbell D, Robinson L, Hilstro J, Ruckdeschel JC, Concurrent paclitaxel/cisplatin with thoracic radiation in patients with stage IIIA/B non-small cell carcinoma of the lung. Seminars in oncology, 1995 Aug;22(4 Suppl 9):34-7 | 1995 |
| Wolff AC, Ettinger DS, Neuberg D, Comis RL, Ruckdeschel JC, Bonomi PD, Johnson DH, Phase II study of ifosfamide, carboplatin, and oral etoposide chemotherapy for extensive-disease small-cell lung cancer: an Eastern Cooperative Oncology Group pilot study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995 Jul;13(7):1615-22 | 1995 |
| Wagner H Jr, Lad T, Piantadosi S, Ruckdeschel JC, Randomized phase 2 evaluation of preoperative radiation therapy and preoperative chemotherapy with mitomycin, vinblastine, and cisplatin in patients with technically unresectable stage IIIA and IIIB non-small cell cancer of the lung. LCSG 881. Chest, 1994 Dec;106(6 Suppl):348S-354S | 1994 |
| Lad T, Piantadosi S, Thomas P, Payne D, Ruckdeschel J, Giaccone G, A prospective randomized trial to determine the benefit of surgical resection of residual disease following response of small cell lung cancer to combination chemotherapy. Chest, 1994 Dec;106(6 Suppl):320S-323S | 1994 |
| Remick SC, Reddy M, Herman D, Grace C, Harper G, Willis K, Candon B, Horton J, Ruckdeschel JC, Continuous infusion bleomycin in AIDS-related Kaposi's sarcoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1994 Jun;12(6):1130-6 | 1994 |
| Grossman SA, Finkelstein DM, Ruckdeschel JC, Trump DL, Moynihan T, Ettinger DS, Randomized prospective comparison of intraventricular methotrexate and thiotepa in patients with previously untreated neoplastic meningitis. Eastern Cooperative Oncology Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1993 Mar;11(3):561-9 | 1993 |
| Moffett MJ, Ruckdeschel JC, Bleomycin and tetracycline in malignant pleural effusions: a review. Seminars in oncology, 1992 Apr;19(2 Suppl 5):59-62; discussion 62-3 | 1992 |
| Simon GR, Ruckdeschel JC, Williams C, Cantor A, Chiappori A, Rocha Lima CM, Antonia S, Haura E, Wagner H, Robinson L, Sommers E, Alberts M, Bepler G, Gefitinib (ZD1839) in previously treated advanced non-small-cell lung cancer: experience from a single institution. Cancer control : journal of the Moffitt Cancer Center, 2003 Sep-Oct;10(5):388-95 | |
| Yuen AR, Fuks JZ, Ettinger DS, Chang AY, Ruckdeschel JC, Phan SC, Blum RH, Pilot study with weekly chemotherapy for patients with extensive small cell lung cancer: an Eastern Cooperative Oncology Group Study (PA586). The cancer journal from Scientific American, 2000 Jan-Feb;6(1):34-9 | |
| Maroun J, Ruckdeschel J, Natale R, Morgan R, Dallaire B, Sisk R, Gyves J, Multicenter phase II study of brequinar sodium in patients with advanced lung cancer. Cancer chemotherapy and pharmacology, 1993;32(1):64-6 | |
Comment |
| Ruckdeschel JC, Second-line chemotherapy for non-small cell lung cancer. Chest, 2006 Apr;129(4):840-2 | 2006 |
| Ruckdeschel JC, Fatigue is becoming an exhausting problem. Cancer, 2005 Jan 15;103(2):213-5 | 2005 |
| Ruckdeschel JC, Lung and mediastinum. Current opinion in oncology, 1997 Mar;9(2):147-8 | 1997 |
| Ruckdeschel JC, The cost of success in the treatment of thoracic malignancies. Current opinion in oncology, 1995 Mar;7(2):131-3 | 1995 |
| Ruckdeschel JC, Controversy over sclerotherapy for malignant pleural effusions. Annals of internal medicine, 1994 Jul 15;121(2):150; author reply 151 | 1994 |
| Ruckdeschel JC, Cellular characterization of lung cancer. A caveat. Chest, 1993 Aug;104(2):331 | 1993 |
Editorial |
| Ruckdeschel JC, Slow but real progress in the treatment of thoracic malignancies. Current opinion in oncology, 1998 Mar;10(2):119-21 | 1998 |